Non-invasive Prenatal Testing Market to Reach US$ 11.08 Billion by 2033 at a 9.03% CAGR from US$ 5.55 Billion
Non-invasive Prenatal Testing (NIPT) is a modern prenatal genetic screening technique that examines fragments of cell-free fetal DNA present in the maternal bloodstream to evaluate the likelihood of chromosomal abnormalities, including trisomy 21, trisomy 18, and trisomy 13. By offering high accuracy without posing a risk to the fetus, NIPT has become a preferred option for early prenatal...
0 Commentaires 0 Parts 8 Vue 0 Aperçu
SocioMint https://sociomint.com